Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

Structural proteomics - a new driving force in drug discovery

From the identification of first inhibitors to lead optimisation, having access to high-resolution protein structures is a key advantage in the search for new therapeutic agents.

Judd Berman, Christian Burks, Raymond Hui and Molly B Schmid, Affinium Pharmaceuticals, Inc (June 2004)

Keywords: high-resolution protein structures, drug discovery, structural proteomics, structural genomics,

    View full article    |    Back to Discovery Technology section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |